trending Market Intelligence /marketintelligence/en/news-insights/trending/v2sI7__EZZlwgvD3ZX0W_A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Orthofix settles accounting violations, anticorruption law charges for $14M

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Orthofix settles accounting violations, anticorruption law charges for $14M

Orthofix International NV agreed to pay $14 million to the SEC for improperly booking revenue and paying doctors in Brazil to boost sales.

The Texas-based medical device admitted wrongdoing and agreed to pay the fine to settle the charges stemming from accounting failures that led to misstatements of its accounts for the 2011-2013 period.

The SEC also found that the company violated the Foreign Corrupt Practices Act by making "improper payments" to Brazilian government doctors in an attempt to encourage the prescription and use of its products.

Four former Orthofix executives, including its CFO, also agreed to settle cases related to the accounting failures without admitting or denying the findings.

Orthofix's former CEO Robert Vaters, who was not charged with wrongdoing, reimbursed the company $72,886 for cash bonuses and certain stock awards he received during the period in which the company committed the violations, making it unnecessary for the SEC to pursue an action against him.